Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
MenopauseDepression
Interventions
DRUG

MDD diagnosis and Estrogen treatment

Treatment for major depressive disorder occurring in the context of the menopause while participating in brain imaging sessions pre and post treatment. Women receiving treatment for depression will be compared to normal controls receiving estrogen only for physical symptoms of menopause.

DRUG

MDD diagnosis and Fluoxetine treatment

Menopausal women between the ages of 40-70 diagnosed with Major Depressive Disorder receiving treatment with fluoxetine alone.

DRUG

MDD diagnosis with both Estrogen and Fluoxetine treatment

Menopausal women between the ages of 40-70 diagnosed with Major Depressive Disorder receiving treatment with estrogen and fluoxetine combined.

DRUG

No depression and estrogen treatment

Control participants with no MDD diagnosis received estrogen only for the treatment of physical symptoms of menopause.

Trial Locations (1)

06511

Yale University, New Haven

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT00626340 - Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder | Biotech Hunter | Biotech Hunter